AVIR · Atea Pharmaceuticals, Inc. · Proposed Sales
$3.96
+0.03 (+0.76%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$318.00M
Shares
80.30M
Volume · Nov 20
416.47K
Avg daily vol (3M)
289.48K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-11-19 | BRUNO LUCIDI | Director | 22,619 | 2026-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-19 | BRUCE POLSKY | Director | 8,750 | 2026-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-18 | BRUCE POLSKY | Director | 18,252 | 2026-11-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-17 | BRUNO LUCIDI | Director | 6,741 | 2026-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-17 | BRUCE POLSKY | Director | 8,720 | 2026-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-16 | BRUCE POLSKY | Director | 14,254 | 2026-11-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-12-10 | Franklin Berger | Lead Independent Director | 359,606 | 2024-12-10 | J.P. Morgan Securities LLC |
| 2024-09-19 | JPM Partners LLC | Affiliate | 1,841 | 2024-09-19 | UBS Financial Services Inc. |
| 2024-09-18 | JPM Partners LLC | Affiliate | 22,187 | 2024-09-18 | UBS Financial Services Inc. |
| 2024-09-17 | JPM Partners LLC | Affiliate | 33,941 | 2024-09-17 | UBS Financial Services Inc. |
| 2024-06-20 | Polsky Bruce | Director | 17,544 | 2024-06-20 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES |
| 2024-06-05 | JPM Partners LLC | Affiliate | 1,006 | 2024-06-05 | UBS Financial Services Inc. |
| 2024-02-01 | Jean-Pierre Sommadossi | President, CEO, and Chairman | 65,476 | 2024-02-01 | Morgan Stanley |
| 2024-02-01 | Wayne Foster | EVP, Chief Accounting Officer | 14,311 | 2024-02-01 | Morgan Stanley |
| 2024-02-01 | Maria Arantxa Horga | Chief Medical Officer | 18,227 | 2024-02-01 | Morgan Stanley |
| 2024-02-01 | John Vavricka | Chief Commercial Officer | 13,552 | 2024-02-01 | Morgan Stanley |
| 2024-02-01 | Janet MJ Hammond | Chief Development Officer | 16,110 | 2024-02-01 | Morgan Stanley |
| 2024-02-01 | Andrea Corcoran | CFO, EVP, Legal and Secretary | 18,198 | 2024-02-01 | Morgan Stanley |
Showing 1–18 of 18 filings
Key facts
CIK
1593899
CUSIP
04683R106
13F (30d)
135 filings
118 filers
Visit website
Investor relations